Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes.
Abstract: The occurrence of atherosclerosis and diabetes is expanding rapidly worldwide. These two metabolic disorders often co-occur, and are part of what is often referred to as the metabolic syndrome. In order to determine future therapies, we propose that molecular mechanisms should be investigated. Once the aetiology of the metabolic syndrome is clear, a nutritional intervention should be assessed. Here we focus on the protective effects of some dietary flavonoids, and their metabolites. Further studies may also pave the way for development of novel drug candidates.
Collaboration between DMU-Leicester School of Pharmacy and Dept. Pharmacy & Biotechnology, University of Bologna.
Citation : Zeka, K.; Ruparelia, K.; Arroo, R.R.J.; Budriesi, R.; Micucci, M. (2017) Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes. Diseases, 5 (3), 19
Research Institute : Leicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)
Peer Reviewed : Yes
- Leicester School of Pharmacy